296 related articles for article (PubMed ID: 26786809)
1. Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.
Hernandez-Alcoceba R; Poutou J; Ballesteros-Briones MC; Smerdou C
Immunotherapy; 2016 Feb; 8(2):179-98. PubMed ID: 26786809
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy of cancer based on interleukin 12.
Sangro B; Melero I; Qian C; Prieto J
Curr Gene Ther; 2005 Dec; 5(6):573-81. PubMed ID: 16457647
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy of cancer with interleukin-12.
Mazzolini G; Prieto J; Melero I
Curr Pharm Des; 2003; 9(24):1981-91. PubMed ID: 12871184
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
[TBL] [Abstract][Full Text] [Related]
5. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor.
Jin HT; Youn JI; Kim HJ; Lee JB; Ha SJ; Koh JS; Sung YC
Hum Gene Ther; 2005 Mar; 16(3):328-38. PubMed ID: 15812228
[TBL] [Abstract][Full Text] [Related]
7. Advances in interleukin-12 gene therapy for acquired liver diseases.
Berraondo P; Prieto J; Gonzalez-Aseguinolaza G
Curr Gene Ther; 2009 Apr; 9(2):62-71. PubMed ID: 19355864
[TBL] [Abstract][Full Text] [Related]
8. Cytokine gene therapy using adenovirally transduced, tumor-seeking activated natural killer cells.
Goding SR; Yang Q; Knudsen KB; Potter DM; Basse PH
Hum Gene Ther; 2007 Aug; 18(8):701-11. PubMed ID: 17678438
[TBL] [Abstract][Full Text] [Related]
9. Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas.
Rodriguez-Madoz JR; Zabala M; Alfaro M; Prieto J; Kramer MG; Smerdou C
Hum Gene Ther; 2014 Feb; 25(2):132-43. PubMed ID: 24219025
[TBL] [Abstract][Full Text] [Related]
10. Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity.
Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Miyagi T; Jinushi M; Sakamori R; Kohga K; Uemura A; Ohkawa K; Storkus WJ; Hayashi N
Gene Ther; 2007 Jun; 14(11):863-71. PubMed ID: 17344900
[TBL] [Abstract][Full Text] [Related]
11. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
Gao JQ; Kanagawa N; Motomura Y; Yanagawa T; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
Gene Ther; 2007 Mar; 14(6):491-502. PubMed ID: 17203106
[TBL] [Abstract][Full Text] [Related]
12. Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12.
Waehler R; Ittrich H; Mueller L; Krupski G; Ameis D; Schnieders F
Hum Gene Ther; 2005 Mar; 16(3):307-17. PubMed ID: 15812226
[TBL] [Abstract][Full Text] [Related]
13. Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy.
Ino Y; Saeki Y; Fukuhara H; Todo T
Clin Cancer Res; 2006 Jan; 12(2):643-52. PubMed ID: 16428511
[TBL] [Abstract][Full Text] [Related]
14. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
15. Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12.
Caminschi I; Venetsanakos E; Leong CC; Garlepp MJ; Robinson BW; Scott B
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):347-56. PubMed ID: 10460752
[TBL] [Abstract][Full Text] [Related]
16. Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity.
Salem ML; Gillanders WE; Kadima AN; El-Naggar S; Rubinstein MP; Demcheva M; Vournakis JN; Cole DJ
J Interferon Cytokine Res; 2006 Sep; 26(9):593-608. PubMed ID: 16978064
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells.
Vera M; Razquin N; Prieto J; Melero I; Fortes P; González-Aseguinolaza G
Mol Ther; 2005 Nov; 12(5):950-9. PubMed ID: 15921960
[TBL] [Abstract][Full Text] [Related]
18. Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.
Chen Y; Emtage P; Zhu Q; Foley R; Muller W; Hitt M; Gauldie J; Wan Y
Gene Ther; 2001 Feb; 8(4):316-23. PubMed ID: 11313806
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model.
Nagayama Y; Nakao K; Mizuguchi H; Hayakawa T; Niwa M
Gene Ther; 2003 Aug; 10(16):1400-3. PubMed ID: 12883537
[TBL] [Abstract][Full Text] [Related]
20. Optimization of antitumor efficacy and safety of in vivo cytokine gene therapy using RGD fiber-mutant adenovirus vector for preexisting murine melanoma.
Okada Y; Okada N; Mizuguchi H; Takahashi K; Hayakawa T; Mayumi T; Mizuno N
Biochim Biophys Acta; 2004 Feb; 1670(3):172-80. PubMed ID: 14980444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
